Diosgenin has also been reported to inhibit breast cancer stem-like cells through suppression of the Wnt/β-catenin signaling pathway via targeting sFRP4 (secreted frizzled-related protein 4), leading to attenuation of EMT and invasion in breast cancer [16]. Here, SFRP4 is linked to breast carcinoma.